Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Addex Therapeutics Ltd ADR (ADXN)

Addex Therapeutics Ltd ADR (ADXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 79,658
  • Shares Outstanding, K 8,212
  • Annual Sales, $ 3,850 K
  • Annual Income, $ -13,710 K
  • 60-Month Beta 2.17
  • Price/Sales 19.01
  • Price/Cash Flow N/A
  • Price/Book 4.32
Trade ADXN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.72
  • Number of Estimates 1
  • High Estimate -0.72
  • Low Estimate -0.72
  • Prior Year -0.78
  • Growth Rate Est. (year over year) +7.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.00 +7.78%
on 09/07/21
10.28 -5.64%
on 09/03/21
-0.25 (-2.51%)
since 08/24/21
3-Month
9.00 +7.78%
on 09/07/21
10.90 -11.01%
on 07/01/21
-0.54 (-5.27%)
since 06/24/21
52-Week
8.88 +9.23%
on 05/13/21
35.00 -72.29%
on 12/24/20
-2.65 (-21.46%)
since 09/24/20

Most Recent Stories

More News
New Strong Sell Stocks for August 20th

ADXN, CSSE, HSDT, LYRA, and TRVN have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2021.

TRVN : 1.2300 (+0.82%)
CSSE : 23.54 (-1.92%)
HSDT : 14.85 (+1.78%)
ADXN : 9.70 (+1.31%)
LYRA : 9.31 (+3.50%)
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q2 Loss, Tops Revenue Estimates

Addex Therapeutics Ltd. Sponsored ADR (ADXN) delivered earnings and revenue surprises of -18.46% and 352.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead...

ADXN : 9.70 (+1.31%)
Addex Therapeutics (ADXN) Sees Hammer Chart Pattern: Time to Buy?

Addex Therapeutics (ADXN) has been struggling lately, but the selling pressure may be coming to an end soon.

ADXN : 9.70 (+1.31%)
J&J (JNJ) Recalls Some Sunscreens Due to Benzene Presence

J&J (JNJ) withdraws five aerosol sunscreen products from the market due to "low levels" of benzene found in some samples.

RHHBY : 46.0100 (-0.88%)
JNJ : 164.36 (-0.30%)
CTLT : 141.34 (+0.23%)
ADXN : 9.70 (+1.31%)
Genocea (GNCA) Begins Phase I/IIa Study for Solid Tumor Drug

Genocea Biosciences (GNCA) doses the first patient in phase I/IIa study on its investigational neoantigen-targeted T-Cell therapy, GEN-011, for solid tumors

TBIO : 37.36 (-0.13%)
GNCA : 2.09 (unch)
CTLT : 141.34 (+0.23%)
ADXN : 9.70 (+1.31%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy begins next week, July 13 - 15, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period...

ACOG.VN : 1.350 (-3.57%)
ACER : 2.56 (-0.97%)
ADXN : 9.70 (+1.31%)
AGRX : 1.0300 (unch)
ATGN : 2.0500 (-2.38%)
ABIO : 2.98 (-1.32%)
AUUD : 2.43 (-2.41%)
BASA : 0.3050 (-4.09%)
BMRA : 5.13 (+10.80%)
BKTI : 2.91 (+0.34%)
BSFC : 6.3000 (-1.56%)
DTST : 4.58 (-2.35%)
DCTH : 9.85 (+1.13%)
DMIFF : 0.2478 (+3.25%)
DLPN : 11.54 (-4.63%)
FLUX : 5.70 (-2.81%)
GBNH : 7.47 (-0.40%)
HAVLF : 0.2389 (-3.28%)
ISDR : 25.65 (-4.68%)
INLB : 1.6900 (+5.63%)
KNWN : 2.6375 (-1.95%)
LXXGF : 0.3200 (-2.26%)
MKTY : 8.18 (-2.62%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0900 (unch)
NEPH : 9.10 (+4.24%)
NMTC : 4.18 (-1.18%)
NLSP : 2.59 (+1.97%)
OBLG : 2.20 (-1.79%)
PBLA : 2.19 (-4.37%)
POSAF : 0.9800 (-2.00%)
PCSA : 7.90 (+1.41%)
PTIX : 2.07 (+4.55%)
QOEG : 0.0999 (+41.50%)
QIPT : 5.90 (-1.17%)
SNGX : 1.0250 (-1.44%)
STRR : 2.57 (+0.78%)
TGCB : 0.7500 (unch)
VERB : 1.7900 (-3.76%)
WTEQ.CN : 0.105 (-4.55%)
WINT : 1.8900 (-0.53%)
AYRO : 3.60 (-1.10%)
BCTX : 9.19 (+10.99%)
BTX : 9.48 (-5.58%)
HWAL : 1.7520 (unch)
NMRD : 6.10 (+1.84%)
THBRF : 3.9500 (+2.60%)
TRIQ : 0.9399 (-1.06%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified...

ACOG.VN : 1.350 (-3.57%)
ACER : 2.56 (-0.97%)
ADXN : 9.70 (+1.31%)
AGRX : 1.0300 (unch)
ATGN : 2.0500 (-2.38%)
ABIO : 2.98 (-1.32%)
AUUD : 2.43 (-2.41%)
BASA : 0.3050 (-4.09%)
BKTI : 2.91 (+0.34%)
BSFC : 6.3000 (-1.56%)
DTST : 4.58 (-2.35%)
DCTH : 9.85 (+1.13%)
DMIFF : 0.2478 (+3.25%)
DLPN : 11.54 (-4.63%)
FLUX : 5.70 (-2.81%)
GBNH : 7.47 (-0.40%)
HAVLF : 0.2389 (-3.28%)
ISDR : 25.65 (-4.68%)
INLB : 1.6900 (+5.63%)
KNWN : 2.6375 (-1.95%)
LXXGF : 0.3200 (-2.26%)
MKTY : 8.18 (-2.62%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0900 (unch)
NEPH : 9.10 (+4.24%)
NMTC : 4.18 (-1.18%)
NLSP : 2.59 (+1.97%)
OBLG : 2.20 (-1.79%)
PBLA : 2.19 (-4.37%)
POSAF : 0.9800 (-2.00%)
PCSA : 7.90 (+1.41%)
PTIX : 2.07 (+4.55%)
QOEG : 0.0999 (+41.50%)
QIPT : 5.90 (-1.17%)
SNGX : 1.0250 (-1.44%)
STRR : 2.57 (+0.78%)
TGCB : 0.7500 (unch)
VERB : 1.7900 (-3.76%)
WTEQ.CN : 0.105 (-4.55%)
WINT : 1.8900 (-0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. The company's lead drug candidate includes dipraglurant, ADX71149 which are in clinical stage. Its Preclinical programs include...

See More

Key Turning Points

3rd Resistance Point 10.15
2nd Resistance Point 9.93
1st Resistance Point 9.81
Last Price 9.70
1st Support Level 9.47
2nd Support Level 9.25
3rd Support Level 9.13

See More

52-Week High 35.00
Fibonacci 61.8% 25.02
Fibonacci 50% 21.94
Fibonacci 38.2% 18.86
Last Price 9.70
52-Week Low 8.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar